Viral infections are important health problems all over the world, both in the developed and developing countries, due to their morbidity and mortality. Among the many viruses, hepatitis B virus (HBV) has chronically infected over 300 million individuals.
SmithKline, Inc. Dimethyl sulfoxide (DMSO) and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) were purchased from Sigma (St. Louis, MO, U.S.A.).
Extract Preparation The dried and powdered aerial parts of G. carolinianum L. (5 kg) were refluxed for 2 h with 95% ethanol (40 l, ϫ3). The extract was filtered and concentrated under reduced pressure. The ethanol extract concentrate (570 g) was dissolved in water (5 l) and successively extracted with petroleum ether (5 l, ϫ4), chloroform (5 l, ϫ3), ethyl acetate (5 l, ϫ3), and n-butanol (4 l, ϫ3). The solvent in each extract was evaporated under reduced pressure. The ethyl acetate extract of G. carolinianum L. (GCEE) was evaporated in vacuo giving a yellow powder (87 g).
Determination of the Total Flavonoid Content
The total flavonoid content in the ethyl acetate extract of G. carolinianum L. was determined using the modified method of Zhuang et al. 14) A 0.5 ml aliquot of properly diluted sample solution was mixed with 2 ml of distilled water and subsequently with 0.15 ml of 5% NaNO 2 solution. After 6 min, 0.15 ml of 10% AlCl 3 solution was added and the mixture was allowed to stand for 6 min, followed by the addition of 2.0 ml 4% NaOH. Distilled water was added immediately to a final volume of 5.0 ml. The solution was then thoroughly mixed and allowed to stand for another 15 min. Absorbance of the solution at 510 nm (UNICO WFZ UV 2000 spectrophotometer, China) was determined against water. Rutin was used as the standard compound for the quantification of total flavonoid content. All values were expressed as mg of Rutin eq. per gram of GCEE. Data were reported as meansϮS.D. from three replicates.
Separation and Identification of the Anti-HBV Compounds The ethyl acetate extract (30 g) of G. carolinianum L. was first fractionated with silica gel column chromatography (mesh 200-300, 500g, 8.0ϫ30.0 cm, Qingdao Marine Chemical Factory, China) into 5 fractions with a gradient mobile phase of chloroform and ethanol. Repeated Sephadex LH-20 column chromatography (25g, 2.0ϫ69 cm, Sigma, U.S.A.) of fraction 1, eluted with chloroform/ethanol (4 : 6-8 : 2, v/v), yielded compounds 1 (105 mg) and 2 (35 mg) (Fig. 1) . Flash column chromatography (silica, mesh 230-400, 8.0ϫ30.0 cm, Merck) of fraction 2 eluted with chloroform/ethanol (95 : 5) afforded compounds 3 (14 mg), 4 (122 mg), and 5 (32 mg). Fraction 3 was subjected to a Sephadex LH-20 column chromatography (25g, 2.0ϫ69 cm, Sigma, U.S.A.) with methanol as the mobile phase to give compounds 6 (35 mg) and 7 (24 mg). Their structures were elucidated on the basis of spectroscopic studies of UV, 1 H-and 13 C-NMR (Bruker DRX-400 spectrometers, U.S.A.) by comparing with that of the authentic samples. [15] [16] [17] [18] [19] [20] [21] Compound 1 was faint yellow crystals (pyridine) with a mp of more than 300°C. The UV l max (MeOH) 
18)
Cell Culture and Experimental Design The human HBV transfected cell line HepG2 2.2.15 was provided by the Chinese Academy of Medical Sciences. Cells were cultured in Dulbecco's Modified Eagle's Medium (DMEM, GIBCO, U.S.A.) supplemented with 10% (v/v) fetal bovine serum (GIBCO, U.S.A.) at 37°C in a humidified incubator with 5% CO 2 . Cells were seeded in 24-well tissue culture plates at approximately 1ϫ10 6 /ml and maintained at confluence for 48 h prior to the initiation of the treatment to allow the HBV DNA levels to stabilize. All samples used in this study were dissolved in DMSO and Lamivudine (3TC) was used as the positive control. Cells were grown in medium containing 0.2% DMSO. The confluent HepG2 2.2.15 cells were fed with the medium containing the indicated concentrations of test samples. The cell culture medium and HepG2 2.2.15 cells were collected right before the first dose (day 0) and after 6, 9, 12 d of treatment . They were stored at Ϫ70°C until analysis. Cell culture medium was used for the measurement of hepatitis B surface antigen (HBsAg) and hepatitis B e antigen (HBeAg).
22)
Cell Viability Assay The cytotoxicities of different extracts and isolated compounds were analyzed by the MTT assay as described. 23) Each experiment was performed in triplicate.
Measurement of HBsAg and HBeAg After incubation with various concentrations of different extracts and isolated compounds at 37°C for 6, 9, and 12 d, the culture medium was collected. The concentration of HBsAg or HBeAg was measured by an enzyme-linked immunosorbent assay (ELISA) kit (Keuh Hua Inc., China) following the manufacturer's protocol. 5) Each experiment was performed in triplicate. The inhibition effect was calculated as follows:
Anti-HBV Activity of Each Solvent Extract of G. carolinianum L.
Five different extracts (ethanol, petroleum ether, chloroform, ethyl acetate, n-butanol) prepared from the aerial parts of G. carolinianum L. were tested for their inhibitory effect on the secretion of HBsAg and HBeAg from HepG 2 2.2.15 cells. The antigens in the culture supernatants were quantified using specific ELISA kits. The anti-HBV activity of each extract was shown by its inhibition of the antigen secretion by HepG 2 2.2.15 cells after treatment with the corresponding extract.
The ethyl acetate extract from the aerial parts of the plant was most effective among all extracts to inhibit the secretion of HBsAg and HBeAg from HepG 2 2.2.15 cells as shown in Table 1 . The ethyl acetate was also the least toxic to cells (data no shown).
The Relationship between Total Flavonoid Content and Anti-HBV Effect Large quantities of flavonoids and tannins were found in the ethyl acetate extract. We investigated the effect of the flavonoid concentration on the secretion of HBsAg and HBeAg. As shown in Fig. 1 
Isolation and Identification of the Compounds in the Ethyl Acetate Extract
In order to identify the active compounds in the ethyl acetate extract, the ethyl acetate extract was separated into 5 fractions and 3 of the 5 fractions were chromatographed. Seven compounds were identified including two tannins and five flavonoids: ellagic acid (1), geraniin (2), quercitrin (3), hyperin (4), hirsutrin (5), quercetin (6), and kaempferol (7) (Fig. 2) . The chemical structures of these compounds were elucidated by comparing their Rf values of TLC and spectral data (UV, 1 H-and 13 C-NMR) with that of the authentic samples.
The HBV Inhibitory Effects of the Identified Compounds All the isolated compounds were evaluated for their anti-HBV activity. Ellagic acid, geraniin and hyperin showed promising activity against HBV (Table 2 ). In HepG 2 2.2.15 cells, ellagic acid, geraniin or hyperin showed no inhibitory effect on cell proliferation up to 200, 200 and 50 mg/ml, respectively, as assessed by the MTT assay. Treatment of HepG2 2.2.15 cells with ellagic acid, geraniin or hyperin at various concentrations for 9 d resulted in a significant reduction of HBsAg and HBeAg secretion in a dose-dependent manner (Fig. 3) . Quercitrin and quercetin showed no inhibitory effect on HBeAg secretion, but hyperin showed significant inhibitory effect on HBsAg and HBeAg secretion.
Among the seven compounds, geraniin exhibited the highest inhibitory effect on HBV antigen secretion. Treatment of HepG 2 2.2.15 cells with geraniin at various concentrations for 9 d resulted in significant reduction of HBsAg and HBeAg secretion in a concentration-dependent manner. Geraniin inhibited HBsAg secretion by 87% and HBeAg secretion by 63.7% at non-cytotoxic concentrations of 200 a) The concentration was determined for each extraction by MTT ensuring that the sample has no inhibitory effect on cell proliferation below this concentration. a) The concentration was determined for each sample by MTT ensuring that the sample has no inhibitory effect on cell proliferation below this concentration. mg/ml, which was higher than that of the positive control Lamivudine, 33.53% and 32.2%, respectively at 200 mg/ml.
DISCUSSION
Flavonoids and tannins are a group of polyphenolic compounds broadly distributed as secondary metabolites in plants and used in pharmaceutical, cosmetic and food industries. Recent interest in these natural products is attributed to their reported biological activities. 24) By sequential organic solvent extractions of the ethanol extract of G. carolinianum L., a domestic plant grown in China, and studying the activities of the extracts by a bioassay, we found a strong anti-HBV activity in the ethyl acetate fraction. Large amounts of polyphenol compounds such as flavonoids and tannins were found in this fraction. It is well-known that the polyphenols bind to proteins to form unstable complexes. 25) Therefore, it is possible that enveloped viruses such as HBV may be affected by polyphenols, since this class of naturally occurring substances might interact with the glycoproteins of the viral envelope.
It has been suggested that the extracts of G. carolinianum L. may contain virus inhibitors. However, the active substances responsible for the antiviral effect have not been identified. In order to identify the active ingredients responsible for the specific antiviral activity, 13) we fractionated the ethyl acetate extract of G. carolinianum L. using column chromatography and identified the following compounds: ellagic acid (1), geraniin (2), quercitrin (3), hyperin (4), hirsutrin (5), quercetin (6) , and kaempferol (7). Among them, ellagic acid has been shown previously to effectively block HBeAg secretion in HepG 2 2.2.15 cells. 5) We evaluated all seven compounds for their anti-HBV activities. Quercetin and kaempferol did not show activities against HBeAg secretion, which might be due to the absence of the saccharide group in their structures. The anti-HBV activities of quercitrin and hirsutrin were lower than that of hyperin, likely due to the differences of saccharide groups. Geraniin showed specific antiviral activity by inhibiting HBsAg and HBeAg secretion in HBV-infected cells. The inhibition ratios of the section of HBsAg and HBeAg by geraniin were 85.78 and 63.7% respectively, comparing with 33.53 and 32.2% respectively, by Lamivudine. The higher anti-HBV activity of geraniin might be attributed to its multi-hydroxy groups. Galactose receptor is known to be present in HepG 2 2.2.15 cell line and geraniin contains one galactose group. Studies of the other possible mechanisms of the activities of geraniin to decrease HBeAg secretion, such as the possible destabilization of the secreted HBeAg, are in progress.
HBeAg is involved in the inhibition of core antigen during viral assembly, 26) and the involvement of HBeAg in host immune tolerance has also been suggested. 27) Since HBeAg is involved in immune tolerance of HBV-infected individuals, our finding suggests that host immune tolerance induced by HBeAg during HBV infection might be overcome by geraniin. The potential therapeutic value of this compound should be explored. Compared with Lamivudine, ellagic acid and hyperin also have higher activities in reducing HBsAg and HBeAg secretion ( Table 2 ). The presence of the anti-HBV compounds geraniin, ellagic acid, hyperin, and others may explain the effectiveness of this plant in folk medicine. 22) And tannins such as geraniin and ellagic acid might play an important role against HBV.
From the structure-activity relationship point of view, it is of great interest to observe that a galactose group at C-3 of quercetin enhances the anti-HBV potency, but not other sugars. Our current data suggest that geraniin, ellagic acid and heparin could be used as lead compounds for the development of novel therapeutics for the treatment of HBV. Further structural modifications might be needed to increase their efficacy and to decrease their cytotoxicity.
In conclusion, we have identified seven known compounds in Geranium carolinianum L., and some of which showed potent anti-HBV activity. Compounds geraniin, ellagic acid and hyperin were found to be the most active molecules among all the isolated compounds. Further chemical transformation of hyperin, ellagic acid and geraniin is in progress to improve their biological profiles. Studies on the mechanisms of their virus inhibition activities are also being pursued.
